Skip to main content

Table 1 Patients characteristics at admission

From: Prognostic value of serum macrophage migration inhibitory factor levels in pulmonary tuberculosis

Characteristics PTB CAP Control
N 287 100 100
Age (years), median (IQR) 57 (49–63) 57 (48–63) 57 (48–63)
Sex-male, n (%) 149 (51.9) 52 (52.0) 52 (52.0)
BMI (kg/m2), median (IQR) 24.3 (23.1–25.9)†‡ 25.8 (24.3–27.4) 26.0 (24.8–28.5)
Current smoker, n (%) 63 (22.0) 24 (24.0) 21 (21.0)
Alcoholism, n (%) 13 (4.5) 4 (4.0) 3 (3.0)
Past history of tuberculosis, n (%) 19 (6.6)
Symptoms, n (%)
 Fever 133 (46.3) 100 (100.0)
 Cough or sputum 148 (51.6) 69 (69.0)
 Dyspnoea 55 (19.2) 59 (59.0)
 Chest pain 21 (7.3) 5 (5.0)
 Wight loss 53 (18.5) 3 (3.0)
Radiography findings
 Cavitary lesion 106 (36.9) 13 (13.0)
 Pleural effusion 54 (18.8) 14 (14.0)
PORT score 90.5 (80.7–105.6) 104.8 (92.5–116.3)
Positive sputum acid-fast smear, n (%) 165 (57.5)
Extent of disease, n (%)
 Minimal to mild disease 160 (55.7)
 Moderate 72 (25.1)
 Advanced disease 55 (19.2)
Drug resistant tuberculosisa, n (%) 38 (13.2)
Disseminated tuberculosis, n (%) 31 (10.8)
Death, n (%) 36 (12.5) 3 (3.0)
Laboratory test
 WBC 109/L 7.95 (7.10–9.33)†‡ 12.1 (9.7–14.2) 5.88 (5.02–7.13)
 CRP, mg/dl 5.14 (4.03–6.55)†‡ 10.15 (6.12–13.21) 0.23 (0.13–0.52)
 IL-6, ng/ml 10.8 (9.0–13.2)†‡ 12.5 (9.8–16.6) 9.4 (6.9–11.9)
 MIF, ng/ml 23.0 (19.1–28.1)†‡ 27.7 (21.7–33.5) 14.3 (10.9–17.2)
 FBG, mmol/l 5.79 (5.01–6.21) 5.66 (4.93–6.02) 5.38 (4.89–5.76)
 Albumin, g/dl 3.4 (3.2–3.7) 3.4 (3.1–3.7) 3.5 (3.2–3.7)
  1. Data are median (interquartile range) or n (%)
  2. †compared with CAP groups by chi-square or Mann–Whitney test and P < 0.05
  3. ‡compared with HC groups by chi-square or Mann–Whitney test and P < 0.05
  4. PTB Pulmonary Tuberculosis, CAP community-acquired pneumonia, BMI body mass index, WBC white blood cell count, CRP C-reactive protein, FBG fasting blood glucose, IL-6 Interleukin 6, MIF macrophage migration inhibitory factor